Literature DB >> 92524

Continuous proliferation of murine antigen-specific helper T lymphocytes in culture.

J Watson.   

Abstract

Murine helper T cells activated to sheep or horse erythrocyte antigens in vivo have been established as continuous cell lines in culture. T cells require the presence of a T-cell growth factor (TCGF) for continuous proliferation. TCGF purified from murine, rat, or human sources all stimulate murine T-cell growth. The T-cell mitogens concanavalin A and phytohemagglutinin do not stimulate cell proliferation in continuous T-cell lines. All cells that grow in the presence of TCGF express Thy-1 antigens. Helper activity of T-cell lines is both antigen specific and effective for syngeneic or F1 B cells. Supernates from T-cell lines do not contain antigen-specific or nonspecific helper factors. Although several T-cell lines have shown stable helper activity for greater than 50 wk in culture, other cell lines have shown a gradual decline in effector function. The procedure used to establish and maintain proliferation of T cells in culture should be suitable for the selection and growth of antigen-specific effector T cells from each subclass.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 92524      PMCID: PMC2185732          DOI: 10.1084/jem.150.6.1510

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  13 in total

1.  Molecular and quantitative analysis of helper T cell-replacing factors on the induction of antigen-sensitive B and T lymphocytes.

Authors:  J Watson; L A Aarden; J Shaw; V Paetkau
Journal:  J Immunol       Date:  1979-05       Impact factor: 5.422

2.  Long term culture of tumour-specific cytotoxic T cells.

Authors:  S Gillis; K A Smith
Journal:  Nature       Date:  1977-07-14       Impact factor: 49.962

3.  Selective in vitro growth of T lymphocytes from normal human bone marrows.

Authors:  D A Morgan; F W Ruscetti; R Gallo
Journal:  Science       Date:  1976-09-10       Impact factor: 47.728

4.  Cloned T-cell lines with specific cytolytic activity.

Authors:  M Nabholz; H D Engers; D Collavo; M North
Journal:  Curr Top Microbiol Immunol       Date:  1978       Impact factor: 4.291

5.  The purification and quantitation of helper T cell-replacing factors secreted by murine spleen cells activated by concanavalin A.

Authors:  J Watson; L A Aarden; I Lefkovits
Journal:  J Immunol       Date:  1979-01       Impact factor: 5.422

6.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

7.  The effect of T cell growth factor on the generation of cytolytic T cells.

Authors:  P E Baker; S Gillis; M M Ferm; K A Smith
Journal:  J Immunol       Date:  1978-12       Impact factor: 5.422

8.  Long-term culture of human antigen-specific cytotoxic T-cell lines.

Authors:  S Gillis; P E Baker; F W Ruscetti; K A Smith
Journal:  J Exp Med       Date:  1978-10-01       Impact factor: 14.307

9.  The role of H-2-linked genes in helper T-cell function. VI. Expression of Ir genes by helper T cells.

Authors:  P Marrack; J W Kappler
Journal:  J Exp Med       Date:  1979-03-01       Impact factor: 14.307

10.  Biochemical and biological characterization of lymphocyte regulatory molecules. I. Purification of a class of murine lymphokines.

Authors:  J Watson; S Gillis; J Marbrook; D Mochizuki; K A Smith
Journal:  J Exp Med       Date:  1979-10-01       Impact factor: 14.307

View more
  154 in total

1.  Cytokine receptor common beta chain as a potential activator of cytokine withdrawal-induced apoptosis.

Authors:  S F Lee; H M Huang; J R Chao; S Lin; H F Yang-Yen; J J Yen
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

2.  Hemopoietic functions of marrow-derived osteogenic cells.

Authors:  D Benayahu; M Horowitz; D Zipori; S Wientroub
Journal:  Calcif Tissue Int       Date:  1992-09       Impact factor: 4.333

3.  Serum proteases alter the antigenicity of peptides presented by class I major histocompatibility complex molecules.

Authors:  L D Falo; L J Colarusso; B Benacerraf; K L Rock
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

4.  T-cell and mast cell lines respond to B-cell stimulatory factor 1.

Authors:  T R Mosmann; M W Bond; R L Coffman; J Ohara; W E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

5.  A first-order reaction controls the binding of antigenic peptides to major histocompatibility complex class II molecules.

Authors:  S N Witt; H M McConnell
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

6.  The Epstein-Barr virus Bcl-2 homolog, BHRF1, blocks apoptosis by binding to a limited amount of Bim.

Authors:  Anthony L Desbien; John W Kappler; Philippa Marrack
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-17       Impact factor: 11.205

7.  Release of interleukin 1 inhibitory activity (contra-IL-1) by human monocyte-derived macrophages infected with human immunodeficiency virus in vitro and in vivo.

Authors:  R M Locksley; S Crowe; M D Sadick; F P Heinzel; K D Gardner; M S McGrath; J Mills
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

8.  Enhancement of interleukin-2 immunotherapy with L-arginine.

Authors:  M D Lieberman; K Nishioka; H P Redmond; J M Daly
Journal:  Ann Surg       Date:  1992-02       Impact factor: 12.969

9.  Fluorosomes: a convenient new reagent to detect and block multivalent and complex receptor-ligand interactions.

Authors:  Hans J Kueng; Calin Manta; Daniela Haiderer; Victoria M Leb; Klaus G Schmetterer; Alina Neunkirchner; Ruth A Byrne; Clemens Scheinecker; Peter Steinberger; Brian Seed; Winfried F Pickl
Journal:  FASEB J       Date:  2010-01-07       Impact factor: 5.191

10.  Both interleukin 2 and a second T cell-derived factor in EL-4 supernatant have activity as differentiation factors in IgM synthesis.

Authors:  K Nakanishi; T R Malek; K A Smith; T Hamaoka; E M Shevach; W E Paul
Journal:  J Exp Med       Date:  1984-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.